GSK plc (LON:GSK) Receives GBX 1,805.83 Average Target Price from Analysts

Shares of GSK plc (LON:GSK) have been given a consensus recommendation of “Moderate Buy” by the seven ratings firms that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is GBX 1,805.83 ($22.70).

Several equities analysts have recently commented on the company. Berenberg Bank decreased their target price on GSK from GBX 1,820 ($22.88) to GBX 1,600 ($20.11) and set a “buy” rating on the stock in a research report on Friday, November 29th. Shore Capital restated a “buy” rating on shares of GSK in a research report on Wednesday, August 28th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 1,850 ($23.25) target price on shares of GSK in a report on Tuesday, September 3rd. Finally, JPMorgan Chase & Co. restated an “underweight” rating on shares of GSK in a research report on Wednesday, December 11th.

Insider Activity at GSK

In related news, insider Jonathan Symonds acquired 7,150 shares of the firm’s stock in a transaction that occurred on Wednesday, October 30th. The stock was acquired at an average cost of GBX 1,394 ($17.52) per share, for a total transaction of £99,671 ($125,277.78). 1.61% of the stock is owned by company insiders.

GSK Stock Performance

GSK opened at GBX 1,308.50 ($16.45) on Friday. The company has a quick ratio of 0.73, a current ratio of 0.82 and a debt-to-equity ratio of 123.04. The business has a 50 day moving average of GBX 1,387.25 and a 200-day moving average of GBX 1,507.27. GSK has a 12-month low of GBX 1,282.50 ($16.12) and a 12-month high of GBX 1,823.50 ($22.92). The stock has a market cap of £53.39 billion, a price-to-earnings ratio of 1,157.96, a PEG ratio of 1.24 and a beta of 0.31.

GSK Dividend Announcement

The company also recently announced a dividend, which will be paid on Thursday, January 9th. Shareholders of record on Thursday, November 14th will be given a GBX 15 ($0.19) dividend. The ex-dividend date is Thursday, November 14th. This represents a yield of 1.03%. GSK’s dividend payout ratio is presently 5,309.73%.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.